<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Genetic changes involving the c-myc oncogene have been observed in human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In particular, the c-myc gene is translocated in Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and is amplified in the human promyelocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> cell line, <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60, which contains double minute chromosomes (DMs) </plain></SENT>
<SENT sid="2" pm="."><plain>More recently, an amplified c-myc gene has been positioned on a chromosomal homogeneous staining region (HSR) in a human <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell line, COLO 320, with neuroendocrine properties </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, c-myc is expressed in increased amounts in some human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> lines, and in some cases, human <z:e sem="disease" ids="C0149925" disease_type="Neoplastic Process" abbrv="SCLC">small cell lung cancers</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCLC</z:e>) contain DMs and HSRs </plain></SENT>
<SENT sid="4" pm="."><plain>These findings prompted us to study the c-myc gene and its <z:chebi fb="40" ids="33697">RNA</z:chebi> expression in a series of human <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> cell lines </plain></SENT>
<SENT sid="5" pm="."><plain>We now report amplification and expression of the c-myc oncogene in a system other than B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, namely human <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Of 18 human <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> cell lines tested, 8 showed an amplified 12.5-kilobase (kb) EcoRI c-myc DNA band </plain></SENT>
<SENT sid="7" pm="."><plain>Of particular interest are five <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCLC</z:e> lines with a high degree of c-myc DNA amplification (20-76-fold) and greatly increased levels of c-myc <z:chebi fb="40" ids="33697">RNA</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> five lines reside in the variant class of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCLC</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCLC</z:e>-V) characterized by altered <z:mp ids='MP_0000002'>morphology</z:mp>, lack of expression of some <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCLC</z:e>-differentiated functions and more malignant behaviour than pure <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCLC</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Three of the five lines which have been karyotyped also contain DMs or HSRs </plain></SENT>
<SENT sid="10" pm="."><plain>The finding of a greatly amplified c-myc gene in <z:hpo ids='HP_0000001'>all</z:hpo> cell lines of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCLC</z:e>-V class examined strongly suggests a role for the c-myc gene in the phenotypic conversion and malignant behaviour of human <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> </plain></SENT>
</text></document>